Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...